Evidence map›Paper›PMID 41095677›Full record

ReviewDiagnostics (Basel, Switzerland)2025

The Value of Baseline [

Alberto Miceli, Maria Librando, Francesco Dondi, Lorenzo Jonghi-Lavarini, Adriana D'Antonio, Antonio Mura, Anna Giulia Nappi, Guido Rovera, Maria Silvia De Feo, Giulia Santo and 1 more

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alberto MiceliNuclear Medicine Unit, Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy.ORCID 0000-0001-6751-2412
Maria LibrandoNuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 98122 Messina, Italy.
Francesco DondiDivision of Nuclear Medicine, Università degli Studi di Brescia and ASST Spedali Civili di Brescia, 25123 Brescia, Italy.ORCID 0000-0003-4839-9033
Lorenzo Jonghi-LavariniDepartment of Radiotherapy and Nuclear Medicine, ASST-Cremona, 26100 Cremona, Italy.
Adriana D'AntonioDepartment of Advanced Biomedical Sciences, University Federico II, 80131 Naples, Italy.
Antonio MuraUnit of Nuclear Medicine, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
Anna Giulia NappiNuclear Medicine Unit, Interdisciplinary Department of Medicine, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70124 Bari, Italy.ORCID 0000-0002-9046-6378
Guido RoveraDepartment of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0003-1839-0206
Maria Silvia De FeoDepartment of Radiological Sciences, Oncology and Anatomo Pathology, Sapienza University of Rome, 00151 Rome, Italy.ORCID 0000-0003-3216-4838
Giulia SantoDepartment of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0001-6565-0686
Francesco LanfranchiDepartment of Experimental Medicine (DIMES), University of Genoa, 16132 Genoa, Italy.ORCID 0000-0002-6043-9627

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

positron emission tomographyprognosisprogression-free survivalthymic carcinomathymic epithelial tumoursthymoma

Identifiers

PMID41095677
PMCPMC12523372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.